-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
David Doherty, co-founder of 3G doctor
David Doherty
Interview: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Randomized clinical trials in US hospices: challenges and the current state of the art
Robin L Kruse, Lauren Ashley Gage, Karla T Washington & Debra Parker Oliver
Review: Clinical Trail Outcomes: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Communicating trial results to study volunteers: what does the future hold?
Zachary P Hallinan, Kenneth A Getz
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 4
Acknowledgements: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation
-
Boceprevir in the treatment of hepatitis C infection: rationale and clinical data
Omer Khalid ,Bruce R Bacon
Review Article: Clinical Investigation